FHMLS IX, L.P.'s Net Worth

$137 Million

Who is FHMLS IX, L.P.?

FHMLS IX, L.P. has an estimated net worth of $137 Million. This is based on reported shares across multiple companies, which include Tarsus Pharmaceuticals, Inc., Phathom Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., and Passage BIO, Inc..

SEC CIK

FHMLS IX, L.P.'s CIK is 0001782789

Past Insider Trading and Trends

2020 was FHMLS IX, L.P.'s most active year for acquiring shares with 7 total transactions. FHMLS IX, L.P.'s most active month to acquire stocks was the month of September. 2020 was FHMLS IX, L.P.'s most active year for disposing of shares, totalling 6 transactions. FHMLS IX, L.P.'s most active month to dispose stocks was the month of February. 2019 saw FHMLS IX, L.P. paying a total of $47,325,317.00 for 5,973,183 shares, this is the most they've acquired in one year. In 2019 FHMLS IX, L.P. cashed out on 26,288,940 shares for a total of $0.00, their largest year based on trade value.